Cargando...
Discovery and Validation of New Antitubercular Compounds as Potential Drug Leads and Probes
Increasing multidrug resistance in Mycobacterium tuberculosis continues to diminish the number of effective drugs available for treatment of active tuberculosis. Although there are four new products (representing three new chemical classes) in clinical development, an active, robust pipeline of new...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2009
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2783328/ https://ncbi.nlm.nih.gov/pubmed/19716767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tube.2009.07.007 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|